Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp
CA 1341222 C · Owner: Westermark, Per · Inventors: Johnson, Kenneth H.; Westermark, Per
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Islet amyloid polypeptide substantially free of islet amyloid which can be isolated from islet amyloid of different mammals and when isolated from humans it has the following amino acid sequence in positions 1-37: Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala- Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe- Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr. While other attempts have been made to isolate and characterize the major component of islet amyloid none have, been successful. Proteins containing the amino acid sequence of the polypeptide or of active fragments of the polypeptide may be employed for diagnosis of disease related to the biological function of the polypeptide. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 1, 2001. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 1, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.